Morgan Lewis

Life Sciences Publications of Interest

For More Information

Practice group contacts:

Life Sciences Deskbook

Industry Events

Fast Facts

150 partners and counsel focused on the life sciences industry

60 professionals with advanced scientific degrees

800 active life sciences clients

Honors

PLCCross-border Quarterly 2008 Life Sciences Legal Market Review

  • Industry Super League - Ranked 16th among law firms worldwide
  • Regulatory Super League - Ranked 6th among law firms worldwide

PLCCross-border Life Sciences Handbook 2007/2008

  • U.S. - Recognized for commercial/ partnering, competition/ antitrust, corporate, government law enforcement/ investigations, regulatory, regulatory/ medical devices, and patent counseling
  • England - Recognized for regulatory
  • Japan - Recognized for corporate/commercial

Chambers USA 2008: Recommended in Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory

UK Legal 500 2007/2008: London: Pharmaceuticals and Biotechnology

Clients

16 of the top 20 pharmaceutical companies

7 of the top 20 biotechnology companies

12 of the top 20 medical device companies

110 Publications Found
page 3 of 6
04/17/07 Managing Customer Communications in a Post-Neurontin World, presented at the AdvaMed MTLI Conference: The Regulation of Advertising, Promotion, and Sales of Medical Devices, Washington, D.C.

Presentation | Speech
M. Elizabeth Bierman

04/17/07 The AdvaMed Code of Ethics, presented at the AdvaMed MTLI Conference: The Regulation of Advertising, Promotion, and Sales of Medical Devices, Washington, D.C.

Presentation | Speech
Kathleen Sanzo

03/16/07 U.S. Patent and Trademark Office Issues Notice on Patent Applications Containing Nucleotide Sequences

LawFlash/Client Alert | Intellectual Property LawFlash
Intellectual Property

On March 12, 2007, the U.S. Patent and Trademark Office posted a notice on restriction requirements in patent applications containing nucleotide sequences. The 2007 Notice rescinds a 1996 Notice on the subject and is eff... more

03/15/07 The Six Regulatory Issues That MUST Be Addressed in a Life Sciences M&A, presented to the American Conference Institute, New York

Presentation | Speech
Stephen Mahinka

03/14/07 Unique Challenges in Private Versus Public Life Sciences M&A, presented to the American Conference Institute, New York

Presentation | Speech
Randall Sunberg

03/02/07 Potential Challenges to Pricing of Biotech Products: Medicare/Medicaid and Related Pricing Developments, presented at the 2007 BIO General Counsels' Committee Meeting

Presentation | Speech
Stephen Mahinka, Andrew Ruskin

01/22/07 FTC Critical of Recent “Pay-For-Delay” Settlement Tactics in Hatch-Waxman Patent Litigations; Proposed Senate Bill Would Limit Them

LawFlash/Client Alert | Intellectual Property LawFlash
Intellectual Property

The Federal Trade Commission (FTC), in a statement made by Commissioner Jon Leibowitz before the Senate Judiciary Committee on January 17, expressed its concern over recent court decisions allowing cash or other incentive pa... more

2007 Business Process Outsourcing: Process, Strategies, and Contracts (John Wiley)

Outside Publications | Book
Barbara Melby

November/December 2006 Morgan Lewis on Life Sciences
November/December 2006

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In this Issue:

  • The Next Wave of Wage and Hour Litigation: Pharmaceutical Prod... more

2006/07 Overview of Healthcare Fraud Investigations in the U.S., PLC Cross-border Life Sciences Handbook 2006/07

Outside Publications | Chapter
Stephen Mahinka, Kathleen Sanzo

November 2006 Bringing a Drug to Market in the European Union

White Paper | Morgan Lewis White Paper
Catherine McLoughlin, Anthony Warnock-Smith, Keith Black

For businesses in any industry, the European Union (EU) is a market force to be reckoned with. Currently made up of 25 Member States, the EU is the world’s largest economy by gross domestic product, and it is the third l... more

2 November 2006 Defective Defence, Legal Week

Outside Publications | Article
Anthony Warnock-Smith

10/16/06 Mid-Stage Company Exit Strategies: Path to Glory?, presented at Biotech 2006, Philadelphia

Presentation | Speech
Randall Sunberg

10/06/06 Biotechnology Mergers and Acquisitions, presented at Law Seminars International

Presentation | Speech
Andrew Gilbert, Emilio Ragosa

09/13/06 Finance Sector Mini-Plenary Session, presented at the LES Annual Meeting, New York

Presentation | Speech
Randall Sunberg

09/11/06 From Term Sheet to Contract: A Roadmap for Biotech and Pharma Collaborations, presented at the LES Annual Meeting, New York

Presentation | Speech
Randall Sunberg

July/August 2006 Morgan Lewis on Life Sciences
July/August 2006

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In this Issue:

  • New Developments and Product Liability Implications of FDA Prescription Drug Labeling Rule: <... more

06/30/06 China Revises Its Guidelines for Patent Examination

LawFlash/Client Alert | Intellectual Property LawFlash
Intellectual Property

On May 24, 2005, China’s State Intellectual Property Office (SIPO) promulgated a new version of its Guidelines for Patent Examination. The new Guidelines will be effective as of July 1, 2006. This document highlights som... more

February/March 2006 Morgan Lewis on Life Sciences
February/March 2006

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In this Issue:

  • The Increasing Role of Congressional and Advocacy Strategies for Life Sciences Products:
    more

October/November 2005 Morgan Lewis on Life Sciences
October/November 2005

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In This Issue:

  • Manufacturing Outsourcing in the Medical Device Industry: An Overview of the Process and Key Legal Issues:more

10/17/05 Case Study: Patent Pools in Biotechnology and Medicine, presented at Law Seminars International, Seminar on Standards Setting and Patent Pools, Washington, D.C.

Presentation | Speech
Willard Tom

October/November 2005 Manufacturing Outsourcing in the Medical Device Industry: An Overview of the Process and Key Legal Issues, Morgan Lewis on Life Sciences
October/November 2005

Newsletter | Article
Barbara Melby

In today’s increasingly competitive global economy, medical device companies are continually seeking ways to drive down production costs while at the same time improve quality and accelerate time-to market. Out... more

August/September 2005 Morgan Lewis on Life Sciences
August/September 2005

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In this Issue:

  • Medicare Amendments Preserve Strategic Obstacles for Generics: In the 2003 Medicare Pres... more

07/30/05 Current Trends and Provisions in Pharma-Biotech Strategic Alliances, presented at the International Forum on Biotech Commercialization in Greater China/Asia Pacific, Rutgers Business School, NJ

Presentation | Speech
Randall Sunberg

06/18/05 Starting or Expanding a Pharma/Biotech Business in the U.S.: New Legal and Regulatory Issues, presented at the 6th Annual Philadelphia-Japan Health Sciences Dialogue, Japan America Society, Philadelphia

Presentation | Speech
Stephen Mahinka

page 3 of 6